Early events required for induction of apoptosis by CD95 are preassociation of CD95, the formation of the deathinducing signaling complex (DISC) and clustering of CD95 in distinct membrane domains. Here, we identify the molecular ordering of these events and show that the acid sphingomyelinase (ASM) functions upstream of the DISC to mediate CD95 clustering in ceramide-enriched membrane platforms, an event that is required for DISC formation. Experiments in ASM-deficient cells revealed that CD95 ligation, in the absence of ceramide generation, triggers o1% of full caspase 8 activation at the receptor. This event, however, is both necessary and sufficient to trigger translocation of ASM onto the outer leaflet of the plasma membrane, ASM activation and ceramide release, but insufficient for apoptosis induction. Ceramidemediated CD95 clustering then amplifies the primary CD95 signaling and drives the second step of CD95 signaling, that is, formation of the DISC yielding 100% caspase activity and apoptosis. These studies suggest that the most parsimonious interpretation of the molecular ordering of the earliest events in CD95 signaling, at least in some cells, is: CD95 ligation-1% of maximum caspase 8 activation-ASM translocation-ceramide generation-CD95
Introduction
Multimerization of CD95 results in rapid association of the receptor with an adapter protein, FADD (Chinnaiyan et al., 1995) . This association occurs via the death domain present in both molecules. FADD in turn recruits the initiator caspase 8 to its death effector domain (Boldin et al., 1996; Muzio et al., 1996) . This multiprotein complex composed of multimerized CD95, FADD and caspase 8 has been termed the deathinducing signaling complex (DISC) (Kischkel et al., 1995) . Multimerization of procaspase 8 at the DISC results in caspase 8 autocatalysis that initiates apoptosis induction. Caspase 8 then either directly activates caspase 3 or indirectly activates this caspase via the release of cytochrome c from mitochondria and the association of cytochrome c with APAF-1 and caspase 9 (for review see Green, 1998; Peter and Krammer, 1998) . The latter pathway also serves to amplify CD95 signaling by feeding back on caspase 8, maximizing its activation, which might be critical to mediate cell death upon irradiation (Rudner et al., 2001; Belka et al., 2003) or CD95 ligation at least in some cells originally classified as type II cells (Scaffidi et al., 1998) . Finally, the activation of caspase 3 executes apoptosis by triggering DNA fragmentation and proteolysis of intracellular proteins (Green, 1998; Peter and Krammer, 1998) .
We have recently suggested that alterations of the cell membrane per se might be also critically involved in CD95 signaling Grassme´et al., 2001a, b) . These studies suggested that stimulation of T or B cells via CD95 triggered translocation of the acid sphingomyelinase (ASM) from an intracellular compartment onto the cell surface (Grassme´et al., 2001a, b) . Electron microscopy studies localized ASM in intracellular vesicles of unstimulated cells (Grassme´et al., 2001b) , which appeared to fuse with the cell membrane upon stimulation. This resulted in exposure of the ASM on the extracellular membrane leaflet and formation of ceramide. ASM seemed to release ceramide within small, distinct cholesterol-and sphingolipid-rich domains of the cell membrane, termed rafts that are formed by an association of sphingolipids and cholesterol (for reviews see Simons and Ikonen, 1997; Brown and London, 1998) . Accumulation of ceramide transformed those small sphingolipid-enriched rafts into larger signaling platforms, which trapped and clustered ligated CD95 Grassme´et al., 2001a) . Disruption of rafts using reagents that extract cholesterol from the plasma membrane, or prevention of raft reorganization into larger platforms by inactivation of ASM, rendered cells resistant to CD95 clustering and apoptosis Grassme´et al., 2001a) . Further, very small amounts of natural ceramide restored CD95 clustering and apoptosis in ASM-deficient lymphocytes or hepatocytes (Grassme´et al., 2001a; Paris et al., 2001) , indicating ceramide was required for both events.
The simplest molecular ordering of the early events of CD95 signaling described above would be: receptor ligation-ASM translocation-ceramide generation-CD95 clustering-DISC formation-caspase 8 activation-apoptosis. However, numerous prior studies, confirmed here, demonstrate that ASM-generated ceramide elevation was downstream of FADD and caspase 8 activation (Brenner et al., 1998; Schwandner et al., 1998; Wiegmann et al., 1999; Grullich et al., 2000; Sawada et al., 2002) . The present studies resolve this conundrum and show that minimal (o1%) caspase 8 activation is sufficient for full ASM translocation and the ceramide generation necessary for the other 99% of caspase 8 activation needed for apoptosis. Hence, the actual molecular ordering of the early events of CD95 signaling according to the present data is: CD95 ligation-1% of maximum induced caspase 8 activation-ASM translocation-ceramide generation-CD95 clustering-DISC formation-100% of maximum induced caspase 8 activation-apoptosis.
Results
Previous studies indicated that formation of the CD95-DISC and clustering of CD95 in ceramide-enriched membrane platforms occur very early in the signaling of CD95 (Chinnaiyan et al., 1995; Kischkel et al., 1995; Boldin et al., 1996; Muzio et al., 1996; Cremesti et al., 2001; Grassme´et al., 2001a, b) . In addition, both events are required for the induction of apoptosis upon CD95 stimulation. To define the molecular ordering of these two central elements in CD95 signaling, we initially studied the role of the CD95 death domain for ASM activation, ceramide formation and CD95 clustering. The death domain has been previously shown to be the critical signaling domain for CD95 apoptosis induction (Watanabe-Fukunaga et al., 1992; Itoh and Nagata, 1993; Boldin et al., 1996; Muzio et al., 1996) . Our studies employed lpr-cg mice, which suffer from a point mutation in the death domain of CD95 (WatanabeFukunaga et al., 1992) that disrupts death domain function. Lpr-cg splenocytes failed to translocate ASM onto the cell surface (Figure 1a) , activate ASM and release ceramide (Figure 1b ) or cluster CD95 after stimulation ( Figure 1c ). All of these events were detected in wild-type splenocytes within a few minutes of CD95 activation (Figures 1a-c) .
Since the death domain serves to associate with FADD and the initiator caspase 8, and overexpression of these proteins resulted in ceramide elevation (Grullich et al., 2000) , we tested whether initiator caspases are also involved in the translocation and activation of the ASM, concomitant with ceramide release and CD95 clustering. These experiments were performed on PBLs pretreated with four different caspase inhibitors, the pan-caspase inhibitor ZVAD-fmk and the caspase 8 inhibitors Boc-AEVD-CHO, Ac-YVAD-cmk and AC-IETD-CHO that are relatively selective for caspase 8 at least at the used concentration (Garcia-Calvo et al., 1998) . The results displayed in Figures 2a-d reveal that incubation of human PBLs with 1 mm Ac-YVAD-cmk or Ac-IETD-CHO prevented CD95-mediated ASM translocation and activation (Figures 2a and b) , ceramide release ( Figure 2b ) and CD95 clustering (Figures 2c and d) .
Control studies confirmed that Ac-YVAD-cmk and Ac-IETD-CHO also prevented CD95-induced apoptosis (not shown). Concurrently, human PBLs not treated with the caspase inhibitor readily responded to CD95 ligation (Figures 2a-d) . Similarly, ZVAD-fmk and Boc-AEVD-CHO almost completely prevented ASM translocation, ASM activation and CD95 clustering (not shown). These studies support the notion that ASM activation and CD95 clustering occur downstream of initiator caspase activation.
To define intermediates between CD95 and the ASM, we tested whether translocation of the ASM depends on changes in the cytoskeleton. Previous electron microscopy data localized the ASM to intracellular vesicles prior to stimulation suggesting that these vesicles are mobilized to fuse with the membrane upon CD95 stimulation (Grassme´et al., 2001b) . We, therefore, incubated Jurkat T cells with cytochalasin D or nocodazole that block actin filaments and microtubuli, respectively. Both inhibitors prevented surface translocation of the ASM, formation of ceramide and CD95 clustering (Figures 3a-c) , suggesting the involvement of actin filaments and polymerization of microtubules for membrane remodeling.
These data indicate several components of a signaling cascade leading from CD95 to ASM and ceramide generation and finally receptor clustering. To determine whether a primary role for the death domain, caspase 8 activation and cytoskeletal rearrangements is generation of ceramide to initiate capping, we added natural C 16 -ceramide to ligand-bound splenocytes from lpr-cg mice, peripheral blood lymphocytes (PBLs) pretreated with Ac-YVAD-cmk or Jurkat cells incubated with nocodazole or cytochalasin D. Dihydro-C 16 -ceramide served as a control. The data reveal that addition of C 16 -ceramide was sufficient to restore clustering of ligated CD95 in lpr-cg cells and in cells treated with caspase or cytoskeleton inhibitors (Figures 4a, b) . The inactive isomer dihydro-C 16 -ceramide was without effect. This indicates that clustering of CD95 in ceramide-enriched membrane domains requires neither an intact CD95 death domain nor the function of initiator caspases, actin filaments or microtubuli. These events appear specifically required for the steps involved in ASM activation and ceramide release.
Based on our current understanding of CD95 signaling, this result would appear to represent a paradox; that is, how could caspase 8 be dispensable for capping yet required for apoptosis, if capping was itself necessary for apoptosis induction. To address this issue, we examined the relation between ceramide generation, capping and DISC formation. We hypothesized that cells lacking the ASM should be unable to form a DISC if the DISC depends on capping, while DISC formation should be unaffected if ASM functions downstream of the DISC. The experiments revealed that ASM-deficient B lymphocytes (Niemann-Pick disease type A (NPDA) cells) recruited approximately 70-fold less FADD to CD95 than ASM-retransfected cells or cells treated with C 16 -ceramide that restored CD95 clustering (Figure 5a) . Further, the NPDA cells failed to translocate These studies imply that only minimal caspase 8 activation was necessary and sufficient for ASM activation. To test this directly, we examined translocation of the ASM in NPDA cells, which express an inactive mutant of the ASM, and, as shown above, activate B1% of the usual complement of caspase 8 upon receptor activation. Western blots reveal that detection of this mutant ASM by our anti-ASM antibody was equivalent to the wild-type ASM (not shown). The results demonstrate a very similar amount of ASM on the cell surface in NPDA or normal control cells after CD95 stimulation (Figure 5f ), although only normal cells showed clustering of CD95 (Figure 5g ).
These data indicate that deficiency of ASM activity almost prevented DISC formation entirely, and suggest that as little as 1% caspase 8 activation might be sufficient for ASM activation, ceramide generation and platform formation. Thus, ASM and ceramide function upstream of the DISC and serve to amplify a primary weak caspase 8 signal, and allow, through membrane reorganization, CD95 multimerization, DISC formation and apoptosis induction.
Discussion
It is believed that formation of the CD95-DISC is the earliest signaling event upon CD95 stimulation. Here, we demonstrate that the ASM and ceramide function even earlier and upstream of CD95-DISC formation. These data suggest a two-step model of early CD95 signaling (Figure 5h ): CD95 ligation yields very limited FADD recruitment and caspase 8 activation that are sufficient to trigger ASM translocation to the membrane and ceramide formation, but insufficient to mediate apoptosis. ASM-dependent ceramide generation in sphingolipid-enriched membrane rafts subsequently confers CD95 clustering, which functions as a feedforward amplification mechanism for DISC formation, caspase activation and apoptosis. Thus, although some limited caspase 8 activity is required for ASM translocation and ceramide formation, the clustering of CD95 in ceramide-enriched membrane domains functions upstream of DISC formation. The role of CD95 clustering might be the generation of a close proximity of caspase 8 molecules, that amplifies local proteolysis and, thus, permits full activation of caspase 8, even if relatively few dispersed caspase 8 molecules were originally active. This concept is consistent with our previous findings that forced clustering of CD95 by a high dose of crosslinking anti-CD95 antibodies is sufficient to overcome ASM deficiency and permits apoptosis in cells lacking ASM (Grassme´et al., 2001a) . The notion that CD95 clustering is central to the function of CD95 is in accordance with previous findings showing that extensive aggregation of CD95 is required to trigger CD95 signaling and apoptosis (Schneider et al., 1998; Villunger et al., 2000) . In addition, recent studies demonstrated that self-association of CD95 through a short domain in the extracellular part of the molecule even prior to CD95 ligand binding is necessary but not sufficient for CD95 signaling (Siegel et al., 2000) . This further indicates the significance of the formation of supramolecular CD95 aggregates. The present data indicate a central role of ceramide for the formation of signaling platforms that serve to cluster CD95. However, our data do not exclude other functions of ceramide in different locations in the cell, in particular in mitochondria, endoplasmic reticulum or lysosomes (Hirschberg et al., 1993; Shimeno et al., 1995; Birbes et al., 2001) . In fact, we recently demonstrated that ionizing radiation induces a late-phase ceramide elevation exclusively within the mitochondria of HeLa cells by activation of a mitochondrial form of ceramide synthase (Kolesnick, unpublished data). Thus, topographical distribution of the ceramide-forming enzymes may dictate the intracellular site of ceramide generation during apoptosis induction.
Although our results suggest that a signaling cascade from the death domain of CD95 via FADD and initiator caspases, most likely caspase 8, to actin filaments/microtubuli regulates membrane translocation and activation of the ASM, release of ceramide and CD95 clustering, the clustering process itself appears independent of these structures or molecules, respectively. This is indicated by the finding that C 16 -ceramide is sufficient to trigger clustering of CD95 molecules even in cells from lpr-cg mice or cells that had been treated with the respective inhibitors. Further, C 16 -ceramide did not trigger CD95 clustering in the absence of a stimulatory anti-CD95 antibody or CD95 ligand, indicating that ligand-bound CD95 and ceramide constitute the minimal requirements for CD95 clustering.
Our data indicate that ASM and ceramide serve to amplify the signaling of CD95 at the membrane level. A second level of signal amplification seems to be operative at the level of the mitochondria and the activation of caspase 9. This enzyme has been shown to feedback into an activation of caspase 8 amplifying the original signal to trigger apoptosis (Scaffidi et al., 1998; Rudner et al., 2001; Belka et al., 2003) . This suggests that not only CD95 signaling, but also other apoptotic stimuli, for example irradiation, are controlled by several feedforward mechanisms.
Although it is very likely that caspase 8 is the intermediate between CD95 and ASM, since no other caspases have been identified to be activated by CD95 within minutes (Siegel et al., 2000) , we cannot formally exclude that another unidentified, Ac-YVAD-cmk-, AC-IETD-CHO-and Boc-AEVD-CHO-sensitive caspase mediates ASM surface translocation and activation. The notion that ASM-mediated CD95 clustering depends on the function of FADD and caspase 8 is consistent with a previous report demonstrating that expression of a limited amount of FADD or caspase 8, which was insufficient for apoptosis induction, nevertheless triggered ceramide release (Grullich et al., 2000) . A similar pathway had been suggested to be active upon TNF-receptor ligation with an ASM-mediated ceramide release via the death domain of the TNF receptor, association with FADD and stimulation of caspase activity (Schwandner et al., 1998; Wiegmann et al., 1999) . Although the ASM sequence reveals potential cleavage sites for caspase 8, preliminary data using caspase inhibitors suggest that the ASM is not a direct The inactive isomer dihydro-C 16 -ceramide was without effect. C 16 -ceramide or dihydro-C 16 -ceramide (1 mm each), respectively, were added to the samples 5 min prior to addition of 50 ng/ml anti-CD95 CH11 or 100 ng/ml anti-CD95 JO2, respectively. Cells were incubated for 5 min with anti-CD95 antibodies and clustering was analysed in 200 cells/sample. The mean7s.d. of three independent studies is shown CD95 clustering H Grassme et al target of caspase 8. This is also in accordance with the topology of the ASM, which localizes to intracellular vesicles and, thus, is physically separated from caspase 8. We would, therefore, like to propose that caspase 8 activates, via unknown mediators, actin filaments and polymerization of microtubuli, that trigger translocation of the ASM onto the cell surface. Candidates for these mediators are the small G proteins Ras (Gulbins et al., CD95 clustering H Grassme et al 1995) and Rac (Gulbins et al., 1996) as well as PAK (Rudel and Bokoch, 1997) , molecules shown to be activated by CD95 and known to be involved in cytoskeleton regulation. A role of actin filaments for CD95 clustering is supported by the finding that an ezrin-mediated association of CD95 with actin filaments is required for clustering of CD95 (Parlato et al., 2000) . Pretreatment with cytochalasin D prevented clustering of CD95 on the cell surface consistent with the present data. However, our data do not exclude that in addition to a regulation of the ASM, cytoskeleton elements might be also involved in the formation and/or stabilization of membrane platforms. Thus, an inhibition of the cytoskeleton might affect receptor clustering on different levels.
Our studies indicate a clustering of CD95 in ceramideenriched rafts within minutes after stimulation, a finding that was recently confirmed by results of six independent groups (Fanzo et al., submitted for publication). These groups showed rapid CD95 clustering in T and B lymphocyte lines, human and murine primary lymphocytes, epithelial cells, hepatocytes and granulosa cells upon stimulation with three different CD95 antibodies (CH11, APO-1-3 and JO2) or recombinant CD95 ligand. However, a recent study (Algeciras-Schimnich et al., 2001) failed to detect clustering of CD95 early after stimulation and demonstrated a late clustering of CD95 that was blocked by a caspase inhibitor. In this study, Fc-receptors on B lymphocytes were not blocked and the cells were fixed after staining and immobilization to poly-l-lysine, which results in technical problems that preclude detection of early clustering (Fanzo JC þ populations (Kirschnek et al., 2000) and P. aeruginosa-induced sloughing of pulmonary epithelium , events mediated by CD95 activation in vivo and prevented by ASM deficiency, ASM-mediated ceramide generation appears obligate. Nevertheless, ASM-deficient mice do not develop lymphadenopathy, a hallmark of the lpr-phenotype that suffers from CD95 inactivation in vivo. Since mice transgenic for CrmA also do not develop a T-cell hyperplasia, although the T cells are resistant to CD95-mediated apoptosis (Smith et al., 1996) , a defect of CD95-mediated apoptosis might not be sufficient to develop an lpr-phenotype. The lpr-phenotype might involve additional functions of CD95, for example, its cooperation with the TCR/CD3 (Desbarats et al., 1999) or the regulation of tyrosine kinases, which have been shown to be deregulated in lpr-lymphocytes (Altman, 1994; Samelson et al., 1996) . These functions of CD95 might be independent of ASM and ceramide-mediated CD95 clustering and, in fact, data from our group show that CD95-mediated caspase 1 activation and interleukin-1 release is independent of ASM expression and ceramide-mediated capping of CD95 . In addition, thymocytes and some B cell clones seem to contain CD95 constitutively within rafts (Hueber et al., 2002; Gulbins et al., unpublished data) , and hence may cluster CD95 by a process that is ceramide-independent or mediated by other mechanisms for ceramide generation such as stimulation of neutral sphingomyelinase, activation of de novo synthesis or degradation of complex glycosphingolipids. Thus, a defect in the ASM very likely does not result in an altered thymocyte maturation and CD95 signaling in some B cell clones, which might preclude development of an lpr-phenotype in ASM-deficient cells. In this regard, it is interesting to note that CD95-mediated , that express an inactive mutant of the ASM, still translocate the mutant ASM protein onto the cell surface (f) although they fail to cluster CD95 (g) and to form a DISC (a, c). ASM translocation was determined by FACS analysis, clustering by fluorescence microscopy. Representative data and the mean7s.d. of five independent experiments, respectively, are shown. (h) The model displays that CD95 clustering serves as a feed-forward mechanism required to amplify the primary weak signal generated by binding of the ligand to CD95. Although the initial signal is insufficient to trigger apoptosis, it mediates a surface translocation of the ASM, a release of ceramide in rafts and the formation of larger signaling platforms. Clustering of CD95 in those platforms then permits efficient FADD recruitment and caspase 8 activation, finally leading to apoptosis 3 CD95 clustering H Grassme et al proliferation of T cells from patients with Systemic Lupus Erythematosis was blocked by the competitive inhibitor of ceramide synthase, fumonisin B1 (Sakata et al., 1998) . Finally, our data indicate that capping functions as a mechanism to amplify CD95 signaling. In an acute stimulation of CD95, for example in stress situations, such an amplification might be predominantly determined by the local strength of the signal; however, in prolonged stimulation type situations, for example development of the immune system, the duration of the signal might also be important and substitute at least partially for the defect of the ASM, preventing development of an lpr-phenotype. Rapid clustering has been described for many receptors upon stimulation. Our data suggest, that for CD95 and perhaps for other TNF receptor superfamily members that activate ASM (p75NGF, TNF receptor, CD40, etc.), clustering functions as a feed-forward mechanism required to amplify the primary signal to a level, sufficient to confer the receptor's biological function. Once clustered, liganded receptor would transactivate whatever receptor-and cell-type specific downstream effector complexes it utilizes for signal transmission. Data to support this assertion for CD40 are already published (Grassme´et al., 2002) . Thus, amplification of the signal strength may be a general function of ceramide-mediated receptor clustering.
Methods

Cells and stimulation
Jurkat and JY were from ATCC. Human ASM-deficient lymphocytes were obtained from a patient with NPDA as described (Grassme´et al., 2001a) . Murine splenocytes were obtained from C57/BL6 lpr-cg mice or normal control mice (kindly provided by Dr T Mo¨ro¨y, University of Essen, Germany). Human PBL were from healthy volunteers. All primary murine or human lymphocytes were purified via a Ficoll gradient (Histopaque; Sigma, St Louis, MO, USA). Murine splenocytes were cultured for 6 days with 10 mg/ml PHA and 10 U/ml murine IL-2 to trigger CD95 expression. Human PBLs were treated with 10 mg/ml PHA and 10 U/ml human IL-2 for 5 days. All cells were cultured in phenol redfree RPMI-1640 supplemented with 10% fetal calf serum (FCS), 10 mm HEPES (pH 7.4), 2 mm l-glutamine, 1 mm sodium pyruvate, 100 mm nonessential amino acids, 100 U/ml penicillin, 100 mg/ml streptomycin (all Life Technologies) and 50 mm b-mercaptoethanol. Reconstitution of NPDA cells with ASM was performed by electroporation of a previously described expression vector for ASM (pJK-asm) (Brenner et al., 1998) . This construct regulates gene expression under control of an elongation factor promoter. FACS and ASM Anti-human CD95 antibodies CH11 were from UBI (Lake Placid, NY, USA) and anti-CD95 APO-1-3 and anti-murine CD95 antibodies JO2 were from Pharmingen (San Diego, CA, USA). C 16 -ceramide and dihydro-C 16 -ceramide were suspended in 0.01% octylglucopyranoside and used at a final concentration of 1 mm. C 16 -ceramide and dihydro-C 16 -ceramide were incorporated into the cell membrane to similar degrees. This was evidenced in experiments that separated cellular lipids after chloroform/methanol extraction by thin layer chromatography and iodine vapor analysis of the lipids. In addition, Triton X-100 resistant rafts, which were purified via sucrose gradient centrifugation, contained C 16 -ceramide, while dihydro-C 16 -ceramide was not enriched in those membrane fractions (E Gulbins, unpublished data). Finally, we have previously shown that a fluorescent-labeled monoclonal anti-ceramide antibody specifically binds to cells that were treated with C 16 -ceramide (Grassme´et al., 2001b) . These studies also revealed that C 16 -ceramide spontaneously aggregates to larger platforms in the cell membrane. Cytochalasin D (5 mm) or Nocodazole (20 mm) (both from Sigma) were added 30 min prior to stimulation of the cells via CD95. Cytochalasin D disrupts actin filaments, nocodazole blocks the assembly of microtubules.
To inhibit caspase 8, the cells were incubated for 20 min with 1 mm of the relatively specific caspase 8 inhibitors Boc-AEVD-CHO, Ac-YVAD-cmk and Ac-IETD-CHO and the nonspecific caspase inhibitor Z-VAD-fmk. All inhibitors were purchased from Bachem, Heidelberg, Germany.
FACS studies
To detect surface ASM by FACS, cells were stimulated with anti-CD95 CH11 (50 ng/ml) or JO2 (100 ng/ml) at 371C, washed with ice-cold PBS supplemented with 1% FCS and 0.1% NaN 3 and blocked for 20 min with the same buffer. Cells were washed and Fc receptors were neutralized by incubation with an irrelevant rabbit Ig (20 mg/ml, Sigma) for 45 min prior to addition of the primary antibodies. Cells were washed again and incubated for 45 min with 1 mg/ml of a polyclonal anti-ASM antibody (Santa Cruz Inc., Santa Cruz, CA, USA) in PBS, 1% FCS and 0.1% NaN 3 . Cells were rewashed and labeled for 45 min with 1 mg/ml of F(ab 0 ) 2 fragments of Cy3-coupled donkey anti-goat antibodies (Jackson ImmunoResearch), washed in PBS and subjected to FACS analysis using a BD-Calibur.
Apoptosis
Apoptosis of lymphocytes was measured by binding of Fluoslabeled Annexin V (Roche, Mannheim, Germany). Cells were washed in 10 mm HEPES (pH 7.4), 140 mm NaCl and 5 mm CaCl 2 , resuspended in the same buffer supplemented with Fluos-labeled Annexin V (1 : 100 dilution) and incubated for 15 min at room temperature. Cells were rewashed and subjected to FACS analysis. Apoptosis was confirmed by DNA fragmentation using 10 mCi/ml [ 3 H]thymidine (8.3 Ci/ mmol, NEN, Boston, MA, USA) labeling of the cells as described (Gulbins et al., 1995) .
ASM activity
ASM activity was determined as described (Grassme´et al., 1997) . PBLs were stimulated via CD95 at 371C, lysed in 50 mm Tris (pH 7.4), 10 mm bacitracin, 1 mm benzamidine, 1 mm Na 3 VO 4 , 10 mg/ml aprotinin and leupeptin (A/L), 0.1 mg/ml soybean trypsin inhibitor and 0.2% Triton X-100, and immediately sonicated three times for 10 s each. Nuclei were removed by 2 min centrifugation at 600 g and the samples were supplemented with an equal amount of 50 mm Tris (pH 7.4), 3% Nonidet P40 (NP40), 1% Triton X-100, 1 mm Na 3 VO 4 , and 100 mg/ml A/L (ASM lysis buffer). ASM was immunoprecipitated with 5 mg/ml polyclonal goat anti-ASM antibodies (Santa Cruz Inc.) for 4 h at 41C. The immunocomplexes were immobilized with protein A/G-coupled agarose (Santa Cruz Inc.), washed three times with ASM lysis buffer, three times with 50 mm sodium acetate (pH 5.0), 0.2% Triton X-100, 1 mm Na 3 VO 4 , 10 mg/ml A/L and finally incubated for 30 min at 371C in 30ml of [ 
Ceramide release
Following stimulation of the cells via CD95, lipids were extracted with CHCl 3 : CH 3 OH : HCl (100 : 100 : 1, v/v/v), an aliquot of the organic phase was dried under vacuum and 1,2-diacylglycerol (DAG) was destroyed by mild alkaline hydrolysis in 0.1 m methanolic KOH. Samples were re-extracted with CHCl 3 : CH 3 OH : HCl (100 : 100 : 1, v/v/v), and ceramide levels were ascertained by the DAG kinase assay as described (Gulbins et al., 1995; Grassme´et al., 1997) .
Immunoprecipitations
To test for association of CD95 with FADD and caspase 8, CD95 was immunoprecipitated and the presence of FADD or caspase 8 was determined. For these studies, 10 7 ASMdeficient NPDA or ASM retransfected NPDA cells/sample were stimulated with 50 ng/ml anti-CD95 CH11 or left unstimulated. When indicated, 1 mm C 16 -ceramide was added to the NPDA cells during the stimulation with anti-CD95 CH11. C 16 -ceramide was dissolved in 5% octylglucopyranoside and sonicated for 10 min prior to use. The final concentration of octylglucopyranoside was at 0.01%. Cells were lysed in ice-cold 30 mm Tris/HCl (pH 7.5), 150 mm NaCl, 2 mm EDTA, 10 mg/ml of each A/L, 1% Triton X-100 and 10% glycerol. Anti-CD95 CH11 was added to the unstimulated samples after lysis. Samples were centrifuged at 14 000 g for 5 min and the supernatants subjected to 4 h immunoprecipitation using 1 mg/ml of anti-CD95 Apo-1-3. Immunoprecipitates were immobilized on protein A/G agarose for 1 h, washed six times in lysis buffer, eluted in 1 Â SDS-sample buffer, boiled, and proteins were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. The blots were incubated with 1 mg/ml of the monoclonal anti-FADD A66-2 antibody (BD-Transduction, Los Angelos, CA, USA) or 1 mg/ml of the monoclonal anti-caspase 8 antibody 1-1-37 (UBI), each labeled with alkaline phosphatase-coupled secondary antibodies (Santa Cruz Inc.) and developed using the Tropix system (Bedford, MA, USA).
Caspase 8 activity
Cells (10 7 cells/sample) were stimulated with 50 ng/ml anti-CD95 CH11, lysed in 25 mm HEPES (pH 7.4), 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 100 mm NaCl, 10 mm NaF, 10 mm Na 2 P 2 O 7 , 10 mm EDTA, and 10 mg/ml each A/L, centrifuged for 5 min at 14 000 g and the supernatants were added to 5 Â reducing SDS-sample buffer. Samples were CD95 clustering H Grassme et al applied to 15% SDS-PAGE, blotted onto nitrocellulose membranes and developed using 1 mg/ml of the anti-caspase 8 antibody 1-1-37 (UBI), followed by an AP-coupled antimouse antibody and the Tropix system.
Fluorescence microscopy
Lymphocytes were washed in H/S (132 mm NaCl, 20 mm HEPES (pH 7.4), 5 mm KCl, 1 mm CaCl 2 , 0.7 mm MgCl 2 and 0.8 mm MgSO 4 ), resuspended in the same buffer, rested for 8 min at 371C and stimulated with 50 ng/ml anti-CD95 CH11 or 100 ng/ml anti-CD95 JO2. Unstimulated samples were incubated with irrelevant isotype IgM or hamster antibodies (Sigma), respectively. Stimulation was stopped by addition of 1 ml ice-cold PBS, 1% FCS and 0.1% NaN 3 , cells were then washed in PBS and fixed in 1% PFA (w/v) in PBS (pH 7.3) for 15 min. Samples were washed in PBS and blocked with 1% FCS in PBS, 1% NaN 3 for 20 min to reduce unspecific antibody binding. To neutralize Fc-receptors on B lymphocytes, samples were incubated with an irrelevant rabbit Ig (20 mg/ml, Sigma) for 45 min prior to addition of the primary antibodies. Cells were then washed in PBS and incubated for 45 min at 41C with 500 ng/ml anti-CD95 CH11 or JO2, respectively, in PBS, 1% FCS and 0.1% NaN 3 . Control samples were incubated with an irrelevant murine IgM or hamster IgG, respectively (both from Sigma). Samples were washed three times in PBS and stained for 45 min with cyanine 3.18 (Cy3)-coupled F(ab 0 ) 2 fragments of donkey anti-mouse IgM antibodies, respectively, or FITC-labeled F(ab 0 ) 2 fragments of goat anti-hamster antibodies (all from Jackson ImmunoResearch, West Grove, PA, USA) in PBS, 1% FCS and 0.1% NaN 3 . Cells were again washed and immobilized on glass cover slips coated with 1% (v/v) poly-l-lysine for 10 min. The cover slips were embedded in Moviol and viewed with a Zeiss Axioplan fluorescence microscope (Jena, Germany) or a Leica TCS NT scanning confocal microscope (Munich, Germany). Clustering was defined as one or several intense spots of fluorescence on the cell surface, whereas unstimulated cells displayed a homogenous distribution of the fluorescence throughout the membrane. In each experiment, the presence or absence of clustering in samples of 200 cells was scored by two independent observers. The results are given as percentage of cells showing a cluster.
Abbreviations DISC, death-inducing signaling complex; ASM, acid sphingomyelinase; PBL, peripheral blood lymphocytes; NPDA, Niemann Pick desease type A; min, minutes; PHA, phyohemagglutinin; TNF, tumor necrosis factor; NGF, nerve growth factor; IL-2, Interleukin 2; Cy3, cyanine 3.18.
